FDA Rejects Disc Medicine’s Porphyria Drug Bitopertin, First Under Makary’s Fast-Track Program
WASHINGTON — The Food and Drug Administration on Friday rejected bitopertin, a treatment developed by Disc Medicine for porphyria, a rare genetic disorder that causes extreme … Read more